The major AlphaFold upgrade has a boost for drug discovery
Google-owned AI firm DeepMind announced it has developed AlphaFold 3, an artificial intelligence tool for drug discovery. “This is exactly what you need for drug discovery: You needs to see how a small molecule is going to bind to a drug, how strongly, and also what else it might bind to,” DeepMind CEO Demis Hassabis said.
The Scale only gets you so far according to the boss of the Artificial Intelligence company
Google DeepMind CEO Demis Hassabis has said the company’s AI model ‘Gemini’ can analyse vast amounts of text, video and audio at a time. The Gemini Pro 1.5 is more powerful for its size and can analyze vast amounts of text, video, and audio at a time. Hassabis had recently given American investor Sam Altman some “healthy competition”, Wired reported.
The head of DeepMind says that it is a new breed of computer-generated objects
Demis Hassabis, Google’s VP of AI and Deep Learning, has said Google’s new AI system Gemini is “substantially” ahead on 30 out of 32 benchmarks compared to OpenAI’sGPT-4. “We’ve done a very thorough analysis of the systems side by side, and the benchmarking,” he further said. Hassabis said Gemini’s “basic models are text-in and text-out” but more powerful models like Gemini Ultra can work with images.